Lapatinib 250 Mg Tablet 250 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg
Reference Brands: Herduo (India), Tykerb (USA/EU)
Category: Oncology Cancer Care
Lapatinib is used in the treatment of breast cancer.
Product Description:
Lapatinib is an oral anticancer medicine used in the treatment of certain types of breast cancer, particularly HER2-positive advanced or metastatic breast cancer. It works as a targeted therapy that blocks specific proteins (HER2 and EGFR receptors) responsible for the growth and spread of cancer cells. Lapatinib is commonly prescribed in combination with other treatments such as capecitabine or letrozole to improve treatment effectiveness in patients whose disease has progressed after other therapies.
This medicine belongs to the class of tyrosine kinase inhibitors and plays an important role in modern oncology treatment strategies. It is typically used when cancer cells overexpress the HER2 receptor, helping slow tumor growth and disease progression. Lapatinib is available in tablet form and is widely used in oncology care across many countries, with the original brand developed by GlaxoSmithKline.
Lapatinib 250 Mg Tablet — third party manufacturing & bulk supply
Lapatinib 250 Mg Tablet 250 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Lapatinib 250 Mg Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lapatinib 250 Mg Tablet →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lapatinib is used for the treatment of HER2-positive breast cancer, particularly advanced or metastatic breast cancer. It is often used in combination with other medicines such as capecitabine or letrozole in patients whose cancer overexpresses the HER2 receptor.
Lapatinib is a synthetic small-molecule tyrosine kinase inhibitor that blocks the activity of HER2 (ErbB2) and EGFR (ErbB1) receptors, which are involved in the growth of certain cancer cells.
The most recognized trade names of lapatinib are Tykerb ,Herduo and Tyverb in different global markets.
The original brand was developed and marketed by GlaxoSmithKline, and now multiple pharmaceutical companies manufacture generic lapatinib tablets worldwide.
The generic name of the medicine is lapatinib ditosylate.
The main brand names are Tykerb, Herduo and Tyverb.
Lapatinib tablets are manufactured in several countries including the United States, European countries, India, and China by approved pharmaceutical manufacturers.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
